Zhao Chenghai, Bu Xianmin, Zhang Ning, Wang Wei
Department of Pathophysiology, China Medical University, Shenyang, PR China.
BMC Cancer. 2009 Jul 9;9:224. doi: 10.1186/1471-2407-9-224.
As negative regulators in Wnt signaling, Secreted Frizzled-Related Proteins (SFRPs) are downregulated in a series of human cancers; and specifically, some matrix metalloproteinases (MMPs), including MMP-2, MMP-7, MMP-9 and MT1-MMP, are frequently overexpressed in gastric cancer. The aim of this study is to determine the expression status of SFRP5 in gastric cancer and explore the correlation between both the expression of SFRP5 and that of these MMPs in this cancer.
Expression of SFRP5, MMP-2, MMP-7, MMP-9 and MT1-MMP was determined by real-time PCR, RT-PCR or Western blotting. The methylation status of SFRP5 was detected by Methylation-specific PCR (MSP). Cell lines with SFRP5 methylation were demethylated by a DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine (DAC). KatoIII cells were transfected with pcDNA3.1 SFRP5 vector to strengthen SFRP5 expression. To abrogate SFRP5 expression in MKN1 cells, SFRP5 RNAi plamid was used to transfect them.
SFRP5 expression was remarkably downregulated in 24 of 32 primary gastric cancer specimens, and even was not detectable in 5 of 8 gastric cancer cell lines. MMP-7 and MT1-MMP mRNA showed a stronger expression in these 24 specimens compared to the other 8 specimens. They also showed higher levels in gastric cancer cell lines AGS and NCI-N87 which had no SFRP5 expression, compared to MKN1 with strong SFRP5 expression. However, they were significantly downregulated, with SFRP5 expression restored in AGS and NCI-N87; and were considerably upregulated with it abrogated in MKN1.
The results indicate there are frequent occurrences of downregualtion of SFRP5 expression in gastric cancer, primarily due to SFRP5 methylation. It seems to be responsible for the upregulation of MMP-7 expression and MT1-MMP expression on the ground that they are inversely correlated with SFRP5 expression.
作为Wnt信号通路中的负调控因子,分泌型卷曲相关蛋白(SFRPs)在一系列人类癌症中表达下调;具体而言,一些基质金属蛋白酶(MMPs),包括MMP - 2、MMP - 7、MMP - 9和MT1 - MMP,在胃癌中经常过度表达。本研究旨在确定SFRP5在胃癌中的表达状态,并探讨SFRP5表达与这些MMPs在该癌症中表达之间的相关性。
通过实时PCR、RT - PCR或蛋白质免疫印迹法测定SFRP5、MMP - 2、MMP - 7、MMP - 9和MT1 - MMP的表达。通过甲基化特异性PCR(MSP)检测SFRP5的甲基化状态。用DNA甲基转移酶抑制剂5 - 氮杂 - 2'-脱氧胞苷(DAC)对具有SFRP5甲基化的细胞系进行去甲基化处理。用pcDNA3.1 SFRP5载体转染KatoIII细胞以增强SFRP5表达。为消除MKN1细胞中的SFRP5表达,使用SFRP5 RNAi质粒转染它们。
32例原发性胃癌标本中有24例SFRP5表达明显下调,8例胃癌细胞系中有5例甚至检测不到SFRP5表达。与其他8例标本相比,这24例标本中MMP - 7和MT1 - MMP mRNA表达更强。与具有强SFRP5表达的MKN1相比,在无SFRP5表达的胃癌细胞系AGS和NCI - N87中它们也显示出更高水平。然而,在AGS和NCI - N87中它们显著下调,SFRP5表达恢复;在MKN1中SFRP5表达被消除时它们则显著上调。
结果表明胃癌中SFRP5表达下调频繁发生,主要是由于SFRP5甲基化。这似乎是MMP - 7表达和MT1 - MMP表达上调的原因,因为它们与SFRP5表达呈负相关。